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A B S T R A C T
The neural crest is a multipotent population of cells that originates a variety of cell types. Many animal models
are used to study neural crest induction, migration and diﬀerentiation, with amphibians and birds being the
most widely used systems. A major technological advance to study neural crest development in mouse, chick
and zebraﬁsh has been the generation of transgenic animals in which neural crest speciﬁc enhancers/promoters
drive the expression of either ﬂuorescent proteins for use as lineage tracers, or modiﬁed genes for use in
functional studies. Unfortunately, no such transgenic animals currently exist for the amphibians Xenopus laevis
and tropicalis, key model systems for studying neural crest development. Here we describe the generation and
characterization of two transgenic Xenopus laevis lines, Pax3-GFP and Sox10-GFP, in which GFP is expressed
in the pre-migratory and migratory neural crest, respectively. We show that Pax3-GFP could be a powerful tool
to study neural crest induction, whereas Sox10-GFP could be used in the study of neural crest migration in
living embryos.
1. Introduction
The neural crest is a multipotent population of cells that arises at
the border between the developing nervous system and surface
ectoderm and originates a variety of cell types, which contribute to
the formation of many organs and systems (LaBonne and Bronner-
Fraser, 1999; Huang and Saint-Jeannet, 2004; Bronner and Simões-
Costa, 2016; Mayor and Theveneau, 2013). This multipotent stem cell
population has fascinated biologists for more than a hundred years, as
it represents an ideal system to study embryonic induction, epithelial-
to-mesenchymal transition, cell migration, diﬀerentiation, and evolu-
tion. The multipotency of the neural crest renders it of great interest for
regenerative medicine and as a therapeutic target for syndromes
associated with this cell population, including many craniofacial
defects (Trainor and Andrews, 2013).
Neural crest cells are a vertebrate invention (Gans and Northcutt,
1983) with potential homologous cell populations in basal chordates.
Many animal systems have been used to study the neural crest (Barriga
et al., 2015). Amphibian and birds have been the most widely used
animals to study induction, migration and diﬀerentiation of neural
crest cells; and more recently mouse and teleosts have joined this list.
Evolutionary studies have been done in basal vertebrates such as
lamprey and hagﬁsh (Sauka-Spengler et al., 2007; Ota et al., 2007).
Chick, frog, mouse and zebraﬁsh are the animal models that have
most contributed to our understanding of neural crest development. In
particular, many of the signals involved in neural crest induction and
the mechanisms that control neural crest migration were identiﬁed in
chick and Xenopus (Milet and Monsoro-Burq, 2012; Theveneau and
Mayor, 2012), and the advent of molecular genetics has revolutionized
the ﬁeld (Bronner and Simões-Costa, 2016). A major technological
advance to study neural crest development has been the generation of
transgenic animals in which neural crest speciﬁc enhancers/promoters
drive the expression of reporter genes in the neural crest. The use of
genetically encoded labelling of neural crest cells has allowed the
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puriﬁcation of neural crest subpopulations in chick (Simoes-Costa and
Bronner, 2016), and the study of neural crest migration in live
zebraﬁsh and mouse embryos (Rodrigues et al., 2012; Ray and
Niswnader, 2016; Corpening et al., 2011; Shibata et al. 2010).
Unfortunately, Xenopus spp., which are ideally suited for exploring
early NC formation, lag behind in the availability of these powerful
transgenic tools to study neural crest development.
Here we describe the generation and characterization of two
transgenic Xenopus laevis lines, Pax3-GFP and Sox10-GFP, with
potential for use in neural crest induction and migration studies,
respectively. We show that Pax3-GFP transgenic embryos express GFP
in early neural crest cells and respond to neural crest inductive signals,
and that Sox10-GFP transgenic embryos express GFP in migrating
neural crest, both ﬂuorescent labels which are readily visible in living
embryos.
2. Material and Methods
2.1. Cloning and transgene generation
A 2.9 kb HindIII-EcoR1 fragment located upstream of the pax3
coding region was cloned into SalI-XbaI digested Tol2 vector
T2AL200R150G (Suster et al., 2009) to form Pax3-GFP. Transient
transgenic embryos were generated by injecting 200 pg of the Pax3-
GFP DNA construct dissolved in 8 nl of water into both blastomeres of
a 2-cell stage embryo as previously described (Mayor et al., 1993).
Stable transgenic animals for Pax3 were generated as described in
Loeber et al. (2009). For the Sox10-GFP construct, a 5.1 kb sequence
was cloned with 5’ Sal1 and 3’ Nsi1 sites using the PCR primers
Sox10FSal1 (GTCGACAAGTCGACCATGAGCCTGGCCTA) and
Sox10RNsiI (ATGCATAAATGCATTTCCAAGAGCGATGTGATTGG),
into a reporter vector that has a separate gamma crystallin - GFP
reporter as an internal positive control for the transgenics. The
amplicon was sub-cloned into the ISce1 vector with HS4 insulators
as described in Rankin et al. (2009). The generation stable transgenic
frogs for Sox10 was performed as described in Ogino et al. (2006a).
2.2. Fertilization, embryo generation and collection
Wild-type female Xenopus laevis were obtained from the
National Xenopus Resource (NXR, Woods Hole, Mass) and housed
at the Cold Spring Harbor Laboratory for use in the Cell and
Developmental Biology of Xenopus course. Female frogs were
injected with 800U of human chorionic gonadotropin and mature
oocytes were collected 12–16 hours later. For the generation of
Sox10-GFP embryos, eggs were in vitro fertilized with sperm from
transgenic male X.l. frogs that express green ﬂuorescent protein
(GFP) under control of the endogenous Sox10 promoter
(Xla.Tg(sox10:GFP)Jpsj, provided by NXR). For the generation of
Pax3-GFP embryos, oocytes were fertilized with sperm from trans-
genic male frogs that express GFP under the Pax3 promoter
(Xla.Tg(2.9pax3:GFP)EXRC). Fertilized embryos were allowed to
develop until the appropriate stage for live imaging or ﬁxation in 4%
PFA for one hour at room temperature. All animal use was
conducted in compliance with the Institutional Animal Care and
Use Committee at the Cold Spring Harbor Laboratory or according
to instructions from the Home Oﬃce of the United Kingdom, where
animal licenses are required. Embryos were obtained and staged as
described previously (Nieuwkoop and Faber, 1967). Transgenic
lines generated in this study (Pax3:GFP and Sox10:GFP) are
maintained at the European Xenopus Resource Centre (EXRC)
and Xenopus National Resource (XNR, Sox-10:GFP only) and
available upon request.
2.3. Whole-mount in situ hybridization (WISH)
Embryos were ﬁxed in 4% Formaldehyde for 2 hours and dehy-
drated in 100% Ethanol. Whole-mount in situ hybridization was
performed according to an optimized protocol for superﬁcial structures
(see for more details Monsoro-Burq, 2007). Anti-sense digoxygenin-
labelled pax3 and sox10 probes (Bang et al. 1997; Aoki et al. 2003)
were synthesized in vitro and used at a ﬁnal concentration of 1 μg/
1ml. Embryos were post-ﬁxed, bleached and images were taken using a
Lumar V12 Binocular microscope equipped with bright ﬁeld and color
camera (Zeiss).
2.4. Imaging the expression of Pax3-GFP and Sox10-GFP and time
lapse microscopy of Sox10-GFP embryos
Pictures of live embryos and larvae stably expressing Pax3-GFP or
Sox10-GFP were taken using a Leica M205 FA Stereo ﬂuorescence
microscope. For time-lapse imaging, Stage 21 Xenopus laevis embryos
expressing Sox10-GFP were placed in 1/3 MMR medium and images
were taken every 6minutes for 12 hours using a Leica M205 FA Stereo
ﬂuorescence microscope.
2.5. Immunoﬂuorescence and cryosection
After ﬁxation, embryos were washed in phosphate buﬀered saline
(PBS), dehydrated through two changes of 100% ethanol and two
changes of 100% methanol (15minutes each), and stored at −20° C in
methanol. Embryos were rehydrated into PBS prior to 48-hour
incubation in 20% sucrose in PBS at 4 ° C. Embryos were then
equilibrated into OCT compound (Fisher Scientiﬁc, Waltham, MA)
through graded washes of 25:75, 50:50, 75:25, 100:0 OCT:20% sucrose
(performed at room temperature, 30min. each). Single embryos were
Fig. 1. Characterization of a pax3 promoter. (A) Graphical representation
showing the result of a comparative genomic analysis obtained using the ECR browser.
The genomic region corresponding to the vertebrate pax3 gene was compared among:
opossum, rat, mouse, dog, and macaque. The pax3 promoter region (2916 bp) is
delimited by two black parallel lines. Black arrow indicates the initiation site. bp, base-
pairs. (B) Schematic showing a simpliﬁed view of the transgene containing the pax3
promoter (2916 bp) driving expression of the green-ﬂuorescent-protein (GFP). Key: red,
highly conserved elements; blue, coding exons; yellow, UTRs; green, transposable
elements and simple repeats.
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embedded in OCT, snap frozen on dry ice, and stored at −80° C. 12μm
transverse embryo sections were obtained through cryo-sectioning and
allowed to dry on glass slides at room temperature overnight. For
immunostaining, sections were rehydrated in PBS (3 × 5min.),
permeabilized with 0.1% Tween-20 in PBS (1 × 10min.), incubated
in permeabilization buﬀer with 10% normal goat serum (block buﬀer, 1
× 1 hour), followed by overnight incubation with primary antibody at
4 ° C (rabbit anti-GFP [Sigma Aldrich, St Louis, MO] at 1:200 dilution
in block buﬀer). Sections were then washed with PBS (3 × 5min.) and
incubated with secondary antibody for 2 hours at room temperature
(Goat anti-rabbit AF 555 [Life Technologies, Carlsbad, CA] at 1:1000
dilution in permeabilization buﬀer). After ﬁnal washes (PBS, 3 ×
15min.), slides were mounted with Fluoromount-G with DAPI
(eBioscience, San Diego, CA). Imaging was performed using an
Olympus FV1000 laser scanning confocal microscope with a 10×
objective, and images were processed using ImageJ to present max-
imum projections of multiple z-planes.
2.6. Dexamethasone treatment
Dexamethasone treatment was performed as described by Kolm
and Sive (1995). Dexamethasone was included in the culture medium
at the indicated stages and maintained until the embryos were ﬁxed.
3. Results and Discussion
3.1. Generation of Pax3-GFP transgenic embryos
To determine the regulatory regions of pax3 in Xenopus laevis,
comparative genomic analysis was employed to identify conserved
elements. Genomic sequences surrounding the pax3 coding region
from diﬀerent vertebrate species were compared in silico (Fig. 1A),
using the Vista ECR browser program. Using a pax3 BAC clone, a
genomic fragment of ∼3 kb, containing ≥29.6% of homology with the
vertebrate species analyzed here, was cloned into a GFP reporter vector
upstream of a thymidine kinase (tk) basal promoter (Uchikawa et al.,
2003). The GFP sequence was placed so that the ATG sequence of GFP
is in the same relative position as the pax3 ATG (Fig. 1B). The
construct was then used to test if this region contains suﬃcient
regulatory elements to recapitulate Pax3 expression during early neural
crest formation.
Pax3-GFP and CMV-GFP (control) plasmids were injected into both
blastomeres of two-cell stage embryos (Fig. 2A) as described in the
Materials and Methods to generate transient transgenic embryos, and
GFP ﬂuorescence was analyzed at neurula stage (Fig. 2B). Injection of
the CMV-GFP construct results in ubiquitous expression (Fig. 2C) as
expected for the CMV promoter, whereas GFP expression upon
Fig. 2. Generation of Pax3-GFP transient transgenic embryos. (A) pax3 or CMV promoters fused to GFP were injected into Xenopus embryos as described to generate transient
transgenic embryos. (B) GFP ﬂuorescence was examined at neurula stage (stage 19). (C) CMV-GFP transient transgenic embryo, showing ubiquitous expression. (D) Pax3-GFP transient
transgenic embryo showing expression restricted to the neural folds. (E, F) In situ hybridization (ISH) for comparison of endogenous Pax3 expression with GFP expression in Pax3-GFP
transient transgenic embryos. (E) ISH for pax3 at the indicated stages. (F) ISH for GFP in Pax3-GFP embryos at the indicated stages. Note the similar expression of Pax3 and GFP. 92%
of Pax3-GFP embryos exhibited expression in the neural folds (n= 210).
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injection of the Pax3-GFP construct is restricted to the neural folds
within the expected Pax3 expression domain (Fig. 2D). To compare
GFP expression driven by the Pax3-GFP construct with endogenous
Pax3 expression, in situ hybridization for Pax3 in wild type embryos
and for GFP in Pax3-GFP transient transgenic embryos were com-
pared. Pax3 is normally expressed at the border between the neural and
non-neural ectoderm (stage 12), in the prospective neural folds of early
neurula embryos (stage 14), and later becomes localized within the
neural folds to include the prospective neural crest and hatching gland
(stage 16) (Monsoro-Burq et al., 2005). Pax3 expression remains in the
neural tube after neurulation is completed, but is switched oﬀ in the
migrating neural crest, and persists in the superﬁcial hatching gland
cells (Fig. 2E; Bang et al., 1997; Monsoro-Burq et al., 2005; Hong and
Saint-Jeannet, 2007). Plasmids injected into Xenopus embryos often
do not express as well as endogenous genes, probably due to limited
diﬀusion of the plasmid and subsequent unequal inheritance by
daughter cells. This explains the spotty pattern of expression in the
Pax3-GFP transient transgenic embryos as compared with the endo-
genous Pax3 expression (Fig. 2E, F). Despite this limitation, a similar
overall pattern of GFP expression is observed in the neural crest of
Pax3-GFP transient transgenic embryos but not in the hatching gland
(Fig. 2F), indicating that the DNA sequence upstream of Pax3 used to
generate the transgenic contains all the regulatory elements required to
recapitulate Pax3 expression in neural crest progenitors and pre-
migratory neural crest.
3.2. Wnt signaling response of Pax3-GFP transgene
As it has been shown that Pax3 expression is positively regulated by
Wnt signaling at the neural/non-neural ectoderm border (NB), which
is among the most important early NB-NC inducing signals (Monsoro-
Burq et al., 2005; Sato et al., 2005; Hong and Saint-Jeannet, 2007), we
tested whether the Pax3-GFP construct was able to respond to Wnt
signaling in transient transgenic Xenopus embryos. Two-cell stage
embryos were injected into the right side blastomeres with an inducible
form of β-catenin (β-Cat-GR) that is activated upon dexamethasone
addition (Domingos et al., 2001). Wild-type embryos activated at stage
11 and ﬁxed at stages 14, 16 and 22 (Nieuwkoop and Faber, 1967)
show a clear induction of Pax3 expression upon dexamethasone
treatment as compared with DMSO control embryos (Fig. 3A,C, E,
quantiﬁcation in Fig. 3G). An equivalent upregulation of GFP is
observed in Pax3-GFP transient transgenic embryos (Fig. 3B,F,D,G),
indicating that the Pax3-GFP transgene responds to Wnt signaling in a
similar manner as the endogenous pax3 gene.
These results show that the pax3 2916 bp genomic fragment
contains suﬃcient elements to respond to neural crest inductive
signals. Thus, this genomic region could potentially be used to study
the molecular aspects of neural crest induction by identifying the
transcription factors that bind and regulate the Pax3 promoter. In
addition, this fragment could be cloned upstream of any gene to drive
neural crest-speciﬁc protein expression. Although the data presented
Fig. 3. Pax3-GFP responds to Wnt signaling. (A, C, E) ISH for endogenous Pax3 in wild type embryos at the indicated stages. (B, D, F) ISH for GFP in Pax3-GFP transient
transgenic embryos at the indicated stages. Embryos were non-injected (Control) or injected with an inducible form of β-catenin (β-Cat-GR) and treated with DXM (in DMSO) to induce
β-catenin, or DMSO alone. (G) Quantiﬁcation of the percentage of embryos that showed expansion in Pax3/GFP expression. Note that activation of β-catenin leads to an equivalent
increase of Pax3 and GFP expression. *** P < 0.001.
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here is from Pax3-GFP transient transgenic embryos, similar patterns
of expression are observed in stable Pax3-GFP transgenic frogs. Stable
transgenic lines have been generated and are maintained at the
European Xenopus Resource Centre (EXRC) where they are available
upon request. It is important to note that, like endogenous Pax3
expression, the Pax3-GFP transgene is switched oﬀ as soon as neural
crest migration starts, and therefore this transgenic Xenopus line
cannot be used to study neural crest migration.
3.3. Generation and characterization of Sox10-GFP transgenic
embryos
As the Pax3-GFP transgene is not expressed in migrating neural
crest, we decided to generate a Sox10-GFP Xenopus laevis transgenic
frog. The sox10 gene was selected due to its strong expression during
neural crest migration (Aoki et al., 2003; Honore et al., 2003). In order
to identify a neural crest-speciﬁc regulatory element of the Xenopus
laevis sox10 gene, an in silico analysis similar to the one described for
pax3 was performed. Genomic sequences upstream of the sox10 coding
region from various vertebrate species were compared in silico (Fig. 4A),
using the Vista ECR browser. A 5.1 kb fragment was identiﬁed and
cloned into a GFP reporter vector upstream of a thymidine kinase (tk)
basal promoter (Uchikawa et al., 2003) as described for the Pax3-GFP
construct (Fig. 4B). Injection of the Sox10-GFP plasmid into Xenopus
embryos generated a pattern of GFP expression similar to endogenous
Sox10 expression indicating that the major Sox10 regulatory elements
are present in the 5.1 kb fragment. Stable transgenic Xenopus laevis
animals were generated with the 5.1 kb fragment as described in the
Materials and Methods. As the main aim for generating this transgenic
Xenopus laevis was to label the migrating neural crest, and because the
expression of GFP in the Sox10-GFP is weak in the pre-migratory neural
crest (data not shown), we focus our description of this new transgenic
line on the neural crest migratory stages, where the expression of Sox10-
GFP is stronger.
Sox10 is normally expressed in all streams of migratory neural crest
and in the otic vesicle (Fig. 5A). This neural crest pattern is reproduced
in the Sox10-GFP stable transgenic embryos (Fig. 5B, C), showing clear
GFP ﬂuorescence in the cephalic neural crest streams at all migratory
stages (Fig. 5D, E). The expression of Sox10 in the otic vesicle (Fig. 5A,
D) is only partially recapitulated in this transgenic frog (Fig. 5B, E),
suggesting that not all of the regulatory elements for the Sox10 gene are
present in the 5.1 kb fragment. However, the expression of GFP in the
neural crest is strong enough to allow direct visualization of GFP
Fig. 4. Characterization of sox10 promoter. (A) Graphical representation showing
the result of a comparative genomic analysis obtained using the ECR browser. The
genomic region corresponding to the vertebrate sox10 gene was compared among:
Xenopus tropicalis, mouse, dog, macaque, rat, and human. The sox10 promoter region
(5.1 kb) is delimited by two black parallel lines. (B) Schematic showing a simpliﬁed view
of the transgene containing the sox10 promoter (5.1 kb) driving the expression of the
green-ﬂuorescent-protein (GFP). Key: red, highly conserved elements; blue, coding
exons; yellow, UTRs; green, transposable elements and simple repeats. Black arrow
indicates the initiation site. bp, base-pairs.
Fig. 5. Characterization of Sox10-GFP stable transgenic embryos. (A-C) Stage 25 embryos. (A) ISH for endogenous sox10 in wild-type embryos at the indicated stage, side
view. (B, C) GFP ﬂuorescence of Sox10-GFP stable transgenic embryos at the indicated stage, B, side view and C, anterior view. (D, E) Stage 30 embryos, side view. (D) ISH for
endogenous sox10 in wild type embryos at the indicated stage. (E) GFP ﬂuorescence of Sox10-GFP stable transgenic embryos at the indicated stage. Note the similar expression of Sox10
and GFP in the migrating neural crest cells (arrows). Arrow head indicates the otic vesicle and e the eye.
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ﬂuorescence and to perform time-lapse imaging of the migrating neural
crest (Movie S1). Histological sections of Sox10-GFP stable transgenic
Xenopus laevis embryos followed by immunostaining against GFP
show that GFP is expressed in the mandibular (Fig. 6A-D, pink arrows),
hyoid (Fig. 6A, D, E purple arrows), branchial (Fig. 6A,E, green arrows)
and trunk (Fig. 6A,F) neural crest.
Supplementary material related to this article can be found online
at http://dx.doi.org/10.1016/j.ydbio.2018.02.020.
These results show that this new Sox10-GFP stable transgenic
Xenopus laevis could be used to study neural crest migration in
amphibians. This new tool will allow researchers to perform live
imaging time lapse microscopy and in addition, could be used to
speciﬁcally label neural crest cells for FACS-sorting and puriﬁcation for
further molecular studies. The Sox10-GFP stable transgenic line is
maintained at the European Xenopus Resource Centre (EXRC) and at
the National Xenopus Resource at the Marine Biology Laboratory
(MBL) where they are available upon request.
4. Conclusions
We have generated both Pax3-GFP and Sox10-GFP transgenic
Xenopus laevis frog lines in which most of the endogenous embryonic
expression of Pax3 and Sox10 are recapitulated. Pax3-GFP could be
used for neural crest induction studies, whereas Sox10-GFP would be
ideal to study neural crest migration. Thus, these two transgenic lines
represent invaluable new tools to mechanistically study these two
distinct processes of neural crest development.
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